Several analysts have recently updated their ratings and price targets for Roche Holding (VTX: ROG):

  • 10/6/2017 – Roche Holding was given a new CHF 260 price target on by analysts at Morgan Stanley. They now have a “neutral” rating on the stock.
  • 10/4/2017 – Roche Holding was given a new CHF 258 price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 10/2/2017 – Roche Holding had its “buy” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 10/2/2017 – Roche Holding was given a new CHF 325 price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 9/25/2017 – Roche Holding was given a new CHF 235 price target on by analysts at BNP Paribas. They now have a “sell” rating on the stock.
  • 9/25/2017 – Roche Holding had its “buy” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 9/21/2017 – Roche Holding was given a new CHF 290 price target on by analysts at Jefferies Group LLC. They now have a “buy” rating on the stock.
  • 9/21/2017 – Roche Holding was given a new CHF 325 price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 9/18/2017 – Roche Holding was given a new CHF 210 price target on by analysts at HSBC Holdings plc. They now have a “sell” rating on the stock.
  • 9/13/2017 – Roche Holding was given a new CHF 295 price target on by analysts at Barclays PLC. They now have a “buy” rating on the stock.
  • 9/12/2017 – Roche Holding was given a new CHF 231 price target on by analysts at Baader Bank. They now have a “neutral” rating on the stock.
  • 9/12/2017 – Roche Holding was given a new CHF 210 price target on by analysts at HSBC Holdings plc. They now have a “sell” rating on the stock.
  • 9/11/2017 – Roche Holding was given a new CHF 230 price target on by analysts at Kepler Capital Markets. They now have a “neutral” rating on the stock.
  • 9/11/2017 – Roche Holding was given a new CHF 300 price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock.
  • 9/11/2017 – Roche Holding was given a new CHF 255 price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 9/11/2017 – Roche Holding had its “buy” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 9/11/2017 – Roche Holding was given a new CHF 325 price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 9/5/2017 – Roche Holding had its “neutral” rating reaffirmed by analysts at UBS AG.
  • 8/24/2017 – Roche Holding was given a new CHF 335 price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 8/15/2017 – Roche Holding was given a new CHF 273 price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 8/8/2017 – Roche Holding was given a new CHF 335 price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.

Roche Holding Ltd. (VTX:ROG) traded up 0.08% during midday trading on Friday, reaching CHK 247.90. The company had a trading volume of 878,888 shares. The company has a 50-day moving average of CHK 244.39 and a 200-day moving average of CHK 251.55. The stock has a market capitalization of CHK 211.52 billion and a PE ratio of 22.01. Roche Holding Ltd. has a 12-month low of CHK 218.30 and a 12-month high of CHK 273.00.

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Receive News & Ratings for Roche Holding Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd and related companies with MarketBeat.com's FREE daily email newsletter.